While romosozumab does appear to be effective at reducing the risk of fracture in women, studies suggest the drug could increase the risk of myocardial infarction.

These pills, which reduce blood pressure, do not improve survival chances for those who have not experienced heart failure, according to researchers.

Researchers have found that Astragalus contains a compound which outperforms current medications for heart attack sufferers.

Scientists have developed a wrist-worn device that could revolutionize treating heart attacks by speeding up diagnosis – without the need to draw blood (the current method).

The virus has long been known to increase the "stickiness" in the blood which, along with inflammation, can weaken fatty plaques in the arteries and cause a clot.

The data also suggests racial disparities in heart attack deaths among White and Black people are shrinking.